《半日速報》恆指半日收報27,530點 升185點; 恆生科技指數半日收報7,504點 升75點 比亞迪升逾8% 創夢天地、中化化肥、東嶽集團、華寶國際、金斯瑞生物科技創新高
恆指半日收27,530點,升185點或0.7%。恆生科技指數報7,504點,升75點或1.0%。國指升77點或0.8%,報9,963點。
活躍重磅股表現:
美團(03690.HK) 收286元,上升2.4%;
港交所(00388.HK) 收499.8元,上升2%;
騰訊(00700.HK) 收530元,下跌1.6%;
平安(02318.HK) 收71.9元,上升0.9%;
友邦(01299.HK) 收93.8元,下跌0.8%;
阿裏巴巴(09988.HK) 收196.8元,上升0.7%;
建行(00939.HK) 收5.56元,上升0.2%;
異動恆指及國指成份股:
比亞迪(01211.HK) 收234.6元,上升8.5%;
農夫山泉(09633.HK) 收42.3元,上升8.3%;
海底撈(06862.HK) 收47.1元,上升6.7%;
京東健康(06618.HK) 收103.6元,上升5.2%;
吉利(00175.HK) 收24.6元,上升4%;
阿裏健康(00241.HK) 收15.64元,上升3.2%;
恆大物業(06666.HK) 收8.55元,下跌3.1%;
異動綜合中小型股:
創夢天地(01119.HK) 收7元,上升13.1%,創新高;
中化化肥(00297.HK) 收1.48元,上升11.3%,創新高;
中興(00763.HK) 收24.1元,上升10%;
東嶽集團(00189.HK) 收10.92元,上升9.3%,創新高;
華寶國際(00336.HK) 收21.85元,上升8.2%,創新高;
金斯瑞生物科技(01548.HK) 收37元,上升6.5%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.